Complies

Related by string. complies * * PDS complies . Complies With *

Related by context. All words. (Click for frequent words.) 76 Complies With 72 Formalizes 71 Regains Compliance 70 Enforces 70 Issues Guidance 70 Fully Compliant 70 Regains Compliance With 69 Reaches Agreement 69 Cooperates 68 Provides Guidance 68 Files Patent 68 Receives Certification 68 Ratifies 68 Approves Merger 68 Receives Approval From 67 Certifies 67 Moves Towards 67 Extends Reach 67 Receives Notification 67 Expands Scope 67 Signs Licensing Agreement 67 Reaches Settlement Agreement 67 Receives Notice From 67 Moves Forward 67 Reaffirms Commitment 67 Verifies 67 Terminates Contract 67 Announces Licensing Agreement 67 Submits Application 66 Aligns 66 Regains Full 66 Files Patent Application 66 Receives Clearance 66 Receives Favorable 66 Announces Stockholder Approval 66 Forges Ahead 66 Conforms 66 Nasdaq Listing Requirements 66 Approve Merger 66 Violates 66 Complete Merger 66 Recertified 66 Modifies 66 Enters Into Exclusive 66 Clears Path 66 Confirms Commitment 65 Reach Settlement Agreement 65 Provides Unprecedented 65 Finalizes 65 Phasing Out 65 Enters Agreement 65 Achieves Milestone 65 Settles Dispute 65 Enacts 65 Agreement Reached 65 Announces Termination 65 Expands Capabilities 65 Resolves Dispute 65 Furthers 65 Settle Patent Litigation 65 Announce Successful Completion 65 Announcement Regarding 65 Ensure Compliance 65 Introduces Breakthrough 65 Completes Integration 65 Non Compliance 65 Provide Comprehensive 65 Proposes Changes 65 Takes Effect 65 Reaches Settlement 65 Ink Deal 65 Pending Acquisition 65 Takes Steps 65 Expresses Disappointment 65 Strikes Deal 65 NASDAQ Listing Requirements 65 Signs Agreements 65 Adopts 65 Pushes Ahead 65 Receives NASDAQ 65 Receives Delisting Notice 64 Unveils Newest 64 Announces Immediate Availability 64 Issues Resolved 64 Obtains Approval 64 Satisfies 64 Fortifies 64 Enters Strategic 64 Wins Approval 64 Formulates 64 BIOLASE Announces 64 Gains Momentum 64 Receives Commitment 64 Issues Statement Regarding 64 Receives Notification From 64 Ink Pact 64 Begins Shipment 64 Regains Nasdaq 64 Underscores Need 64 Reduces Cost 64 Sign License Agreement 64 Strengthens Position 64 Momentum Builds 64 Announce Availability 64 Commercially Available 64 Awarded Patent 64 Enters Into Joint Venture 64 Signs Pact 64 Commences Consent Solicitation 64 Broadens 64 Regains NASDAQ 64 Reach Agreement 64 Expand Relationship 64 Completes Transition 64 Remains Committed 64 Announce Settlement 64 Signs Agreement 64 Must Comply 64 Emphasizes Need 64 Gets Clearance 64 Reach Settlement 64 Reduces Risk 64 Expand Collaboration 64 Provides Update Regarding 64 Announces License Agreement 64 Announces Availability 64 Receives Positive 64 Affirms Commitment 64 Upholds 64 Settles Litigation 64 Proposes Tougher 64 Receives Regulatory Approvals 64 Ups Ante 64 Extends Contract 64 Subsidiary Files 64 Panel Advises 64 Proposes Amendments 64 Announce Agreement 64 Confirms Receipt 64 Announce License Agreement 64 Announces Intent 64 Gains Traction 63 Launches Enhanced 63 Fine Tunes 63 Completes Merger 63 Begins Shipping 63 Reports Inducement Grants 63 Renews Agreement 63 Proposed Revisions 63 Reinforces 63 Rescinds 63 Toughens 63 Announces Enhancements 63 FDA Clears 63 Terminates 63 Collaborates 63 Introduces Next Generation 63 Panel Rejects 63 Introduces Enhanced 63 Announces Expanded 63 Speeds Up 63 Issues Clarification 63 Extend Partnership 63 Momentum Grows 63 Notifies 63 Secures Funding 63 Newest Member 63 Nasdaq Minimum Bid 63 Receives Notice 63 Files Petition 63 Recommends Changes 63 Amplifies 63 Nasdaq Delisting 63 Legislation Introduced 63 Submits NDA 63 Reduces Debt 63 Moves Ahead 63 Files Complaint 63 Validates 63 Seeks Approval 63 Clears Hurdle 63 Continued Listing Requirements 63 Expands Availability 63 Announce Interoperability 63 Revises 63 Widens Probe 63 Unveils Next Generation 63 Shareholders Approve Merger 63 Enables Easy 63 Announces FDA Clearance 63 Extends Offer 63 Enters Into Agreement 63 Closes Merger 63 Concerns Raised 63 Obtains Patent 63 Builds Momentum 63 Conditional Approval 63 Releases Next Generation 63 Deliver Powerful 63 Beefs Up 63 Successfully Demonstrates 63 Receives Authorization 63 Reports Receipt 63 Discontinues 63 Jointly Announce 63 Modernizes 63 Revamps 63 Signs Reseller Agreement 63 Attains 63 Completes Reorganization 63 Settles Charges 63 Achieves Certification 63 Boosts Productivity 63 Demonstrates Commitment 63 Clears Way 63 Continued Listing 63 Finalises 63 Files IND 63 Proposed Rule Changes 63 Be Implemented 63 Refines 63 Compliant 63 Announces Effective Date 63 Subsidiary Enters 62 Retools 62 Submits 62 Makes Headway 62 Warns Consumers 62 Expands Relationship 62 Proves Successful 62 Finds Flaws 62 Terminates Merger Agreement 62 Protects Customers 62 Outlines Strategy 62 Renews Contract 62 Resubmits 62 Flagship Product 62 Strengthens Balance Sheet 62 Formally Launches 62 Statement Regarding 62 Extend Relationship 62 Secures Long Term 62 Annouces 62 Successfully Tested 62 Subsidiary Receives 62 Introduces Unique 62 Demonstrates Significant 62 Study Shows Benefits 62 Interferes 62 Stockholders Approve Merger 62 Releases Enhanced 62 Fully compliant 62 Denies Petition 62 Fast Tracked 62 Board Unanimously Rejects 62 Settles Lawsuit 62 Enters Joint Venture 62 Has Received 62 Extends Leadership 62 Withdraws Application 62 Panel Backs 62 Advises Caution 62 Experts Urge 62 Receives FDA Clearance 62 Being Studied 62 Integrates 62 Successfully Concludes 62 Significantly Reduces 62 Announce Launch 62 Receives Subpoena 62 Achieves Significant 62 Receives Confirmation 62 Withdraws Proposal 62 Advisers Urge 62 Awarded GSA 62 Groups Urge 62 News Unternehmensnachrichten 62 Receives Approval 62 Clarifies Position 62 Strongly Supports 62 Gets Thumbs Up 62 Publicizes 62 Evolves 62 Finalizes Acquisition 62 Clarifies 62 Board Authorizes 62 Announces Dismissal 62 Infringes 62 Receives Patent 62 Enters Into 62 Seeks Input 62 Gaining Momentum 62 Stockholders Approve Acquisition 62 Officially Launched 62 Delivers Comprehensive 62 Option Grants 62 Announces Publication 62 Unifies 62 Recommends Approval 62 Fully Supports 62 Amends 62 Goes Live 62 Gaining Traction 62 Announces Successful Completion 62 Launches Redesigned Website 62 Advises Against 62 Announces Adjournment 62 FCC Approves 62 Helps Ensure 62 Completes Divestiture 62 Platform Enables 62 Achieves ISO #:# Certification [002] 62 Expedites 62 Gives Thumbs Up 62 Expands Reach 62 Inks Deals 62 Amps Up 62 Subsidiary Signs 62 Seeks Injunction Against 62 Demonstrates Interoperability 62 Reiterates Commitment 62 Temporarily Suspends 62 Gets Thumbs Down 62 Jointly Offer 62 Announces Receipt 62 EPA Proposes 62 Signs MOU 62 Delays Filing 62 Extends Collaboration 62 Reshapes 62 Enters Into Partnership 62 Successfully Completed 62 Dramatically Increases 62 Adapts 62 Prolongs 62 HIPAA GLBA 62 FDA Warns 62 Granted Early Termination 62 Injunction Against 62 Spins Off 62 Amend Merger Agreement 62 Complaint Filed 62 Publishes 62 Seeks Tougher 62 Be Enforced 62 Announces Delisting 62 Accredits 62 Sign Licensing Agreement 61 Completes Successful 61 Collaborates With 61 Completes Restructuring 61 FDA Panel Recommends 61 Abandons 61 Reporting Requirements 61 Long Awaited 61 Gives Nod 61 Streamlines Operations 61 Regulatory Requirements 61 Ceases 61 Panel Endorses 61 RoHS Compliance 61 Panel Urges 61 Waives 61 Settle Litigation 61 Strengthens Its 61 Deadline Approaches 61 Complaint Against 61 Announce Licensing Agreement 61 Pushes Back 61 Seek Shareholder Approval 61 Waiting Period 61 Accelerate Adoption 61 Acquire Assets 61 Waiver Request 61 Inks Contract 61 Terminate Agreement 61 Renegotiates 61 Delists 61 Debuts Next Generation 61 STERIS Corporation Announces 61 Announces Shareholder Approval 61 Applauds Decision 61 Website Launched 61 Concerns Arise 61 Patent Dispute 61 Receives Orphan Drug Designation 61 Advises Consumers 61 Launches Breakthrough 61 Enters Into Licensing Agreement 61 Unanimously Approves 61 Introduces 61 Restricts Access 61 Files Suit Against 61 Report Indicates 61 Reaches Pact 61 Paves Way 61 Panel Considers 61 Debate Rages 61 Inks Pact 61 Redesigns Website 61 Enters Into Strategic 61 Highlights Importance 61 Urges Caution 61 Gets Subpoena 61 Previously Announced 61 Successful Launch 61 Redefines 61 Re Affirms 61 Positions Itself 61 Receives CE Marking 61 Launches Next Generation 61 Delist 61 Progresses 61 Extends Relationship 61 Notification Related 61 Widely Available 61 Sign Definitive Agreement 61 Expands 61 Reduces Size 61 Gets Approval 61 Moves Toward 61 Widely Used 61 Regulatory Clearance 61 Repositions 61 Unsolicited Proposal From 61 Results Confirm 61 Significantly Reduce 61 Signs Distribution 61 Relaunches 61 Files Registration Statement 61 Investigates Possible 61 Settle Dispute Over 61 Considers Easing 61 Delivers Enhanced 61 Finalize Agreement 61 Delivers Next Generation 61 Gets FDA Clearance 61 Fully Prepared 61 Could Harm 61 Settlement Reached 61 Releases Latest 61 Completes Reverse Merger 61 Inks Deal 61 Finalizes Agreement 61 Resolve Dispute 61 Signs License Agreement 61 Reaches Deal 61 Rejects Request 61 Updates Shareholders 61 Enforceable 61 Introduces Innovative 61 Launches Unique 61 Receives Initial 61 Reaffirms 61 Postpones Decision 61 Raises Concern 61 Concludes Successful 61 Awarded Patents 61 Entered Into 61 Adjourns 61 INTERNET LAW 61 Unveils Latest 61 Announces Revised 61 Inks Licensing Deal 61 Extends Tender Offer 61 Submits Proposal 61 Demands Removal 61 Starts Shipping 61 Pursues 61 Concerns Remain 61 Announces Favorable Ruling 61 Signs Definitive 61 Provides Comprehensive 61 Receives Unsolicited 61 Nears Launch 61 Defines 61 Patent Lawsuit 61 Signs Licensing 61 Strengthens Commitment 61 Must Disclose 61 Commercializes 61 Enter Into 61 Settles Patent Litigation 61 Officially Released 61 Announces Filing 61 Remain Listed 61 Reconfirms 61 Expands Portfolio 61 Receives Delisting Notification 61 Seeks Clarification 61 Expands Capacity 61 Doubles Capacity 61 Streamlines 61 Signs Deal 61 Favorable Ruling 61 Receives Stockholder Approval 61 Spells Out 61 Receives Funding 61 Deadline Looms 61 Technical Specifications 61 Considers Extending 61 Deliver Comprehensive 61 Seeks Proposals 60 Approves 60 Files Complaint Against 60 House Panel Approves 60 Announce Merger 60 Announces Launch 60 Announce Completion 60 Loses Appeal Against 60 Approves Revised 60 Being Evaluated 60 Sharpens Focus 60 Become Fully 60 Issues Reminder 60 Study Confirms 60 Study Analyzes 60 Gets Mixed Reviews 60 Momentum Continues 60 Significantly Improves 60 Overhauls 60 Standardize 60 Merges 60 Issues Addressed 60 Successfully Launches 60 Milestone Reached 60 Changes Name 60 Panel Recommends 60 Announces 60 Licensing Pact 60 Settle Patent Dispute 60 Intros 60 Filing Requirements 60 Amends Agreement 60 Negotiates 60 NexMed Receives 60 Makes Strides 60 Announce Commencement 60 Applauds Passage 60 Awarded GSA Schedule 60 Announces Organizational Changes 60 Reaches Tentative 60 Receives FIPS #-# 60 Extends Deadline 60 Executes 60 Files Amended 60 Announce Expanded 60 Refile 60 Increases Capacity 60 Reintroduces 60 Announces Favorable 60 Powerful Tool 60 Achieves Highest 60 Complied 60 Finalizes Merger 60 Combats 60 Accelerates Growth 60 Be Abolished 60 Deal Reached 60 Downsizes 60 Launches Innovative 60 Jumpstarts 60 Alleged Violations 60 Rebrands 60 Unveils Groundbreaking 60 Provides Updated 60 Receives Approvals 60 Delay Filing 60 Improve Energy Efficiency 60 Feds Approve 60 Secures Patent 60 Seamless Integration 60 Receives Deficiency Letter 60 Expands Functionality 60 Obtains 60 Successfully Tests 60 Classifies 60 Differentiates 60 Joins Forces 60 Scrutinizes 60 Strengthens Relationship 60 Patents Covering 60 Voluntarily Withdraws 60 Enables Faster 60 Increases Commitment 60 Lawsuits Filed 60 Non Compliant 60 Refocuses 60 Submits Revised 60 Opens Door 60 Inks Distribution 60 Reiterates Support 60 Discloses 60 Issues Statement 60 Launches Website 60 Receives Clearance From 60 Files Lawsuit Against 60 Expands Offerings 60 Announce Early Termination 60 Signs Merger Agreement 60 Broadens Its 60 Receives Complete Response 60 Announce Collaboration Agreement 60 Microchip Technology Introduces 60 Customizes 60 Sign Pact 60 Lauches 60 Listing Compliance 60 Activates 60 Boosts Capacity 60 Testing Capabilities 60 Expands Globally 60 Problems Persist 60 Introduces Revolutionary 60 Groups Oppose 60 Signs Contract 60 Helps Improve 60 Rolled Out 60 Infringed 60 Joins Hands 60 Audit Faults 60 Begin Clinical Trials 60 Gaining Steam 60 Files Suit 60 Voluntarily Delist 60 Reverses Course 60 Applauds Introduction 60 Reach Deal 60 Unveils 60 Enters Negotiations 60 Patent Infringement Lawsuit 60 Bush Embraces Pause 60 Should Reconsider 60 Diversifies 60 Could Prevent 60 Successfully Passes 60 Rapid Expansion 60 Pays Dividends 60 Achieves ISO # 60 Achieves SAS 60 Raises Concerns Over 60 Backs Off 60 Expands Distribution 60 NASDAQ Minimum Bid 60 Gains Ground 60 Greatly Improved 60 Introduces Ultra Low 60 Sounds Alarm 60 Completes Merger With 60 Boosts Buyback 60 Flu Vaccines 60 Retracts 60 Okays 60 Offers Affordable 60 Antitrust Case 60 Announces Signing 60 Develop Next Generation 60 Improves Efficiency 60 Becomes Effective 60 Certification Requirements 60 Licenses Patents 60 Flouts 60 Fills Gap 60 Completes Patient Enrollment 60 Demystifies 60 Hits Milestone 60 Proliferate 60 Battle Heats Up 60 Data Suggest 60 Accepted Into 60 Exceeds 60 Announce Filing 60 Move Quickly 60 Proposed Changes 60 Litig 60 Strengthens 60 Proposed Legislation 60 Regulator Seeks 60 Panel Mulls 60 Stock Soars 60 Being Tested 60 Prescribes 60 Awarded Contract 60 Readily Available 60 Releases 60 Dramatically Reduce 60 Permanent Injunction Against 60 Restates 60 Accelerate Commercialization 60 Debuts 60 Receives Approvable Letter 60 Demonstrate Latest 60 Overturns 60 Updates Status 60 File Lawsuit Against 60 Deliver Innovative 60 Extends Capabilities 60 Explore Strategic Alternatives 60 Final Stages 60 Temporarily Halts 60 Receives Conditional Approval 60 Renews Partnership 60 Solution Enables 60 Lawsuit Settled 60 Launches 60 Delivers Breakthrough 60 Seeks Delay 60 Patented Technology 60 Patent Issued 60 Implements 60 Equips 60 Stricter Rules 60 Deliver Enhanced 60 Adopts Stockholder Rights 60 Quadruples 60 Releases Findings 60 Comment Period 60 Pushed Back 60 Stays Ahead 60 Sweeping Changes 60 Could Prove Costly 59 Entry Into 59 Ramps Up 59 Expand Into 59 Concerns Persist 59 Jointly Develop 59 Shareholders Approve 59 Settles Suit 59 Be Discussed 59 CFO Resigns 59 Acquire Controlling Interest 59 Inks Exclusive 59 Resume Trading 59 Provides Clarification 59 Restate Results 59 FDA Accepts 59 Hits Snag 59 Signs Joint Venture 59 Study Proves 59 Gain Momentum 59 Anounces 59 Unveils Revolutionary 59 Filed Against 59 Photovoltaic Module 59 Gets Tougher 59 Would Require 59 Lays Groundwork 59 Causes Concern 59 Strikes Down 59 Continues Momentum 59 Registration Statement Declared Effective 59 Ramps Up Production 59 Successfully Completes 59 Bulks Up 59 Migrates 59 Withdraws Request 59 Issues Warning 59 Seeks Compromise 59 Differs From 59 Curtails 59 Synchronizes 59 Revenues Decline 59 Deaths Prompt 59 Seasonal Influenza Vaccine 59 Final Approval 59 Heightens 59 Expert Discusses 59 Expands Coverage 59 Misonix Announces 59 Tightens 59 Comply 59 Delivers Unprecedented 59 Releases Latest Version 59 Achieves Record Growth 59 Restate Financials 59 HSR Waiting Period 59 Carotid Artery Stenting 59 Successfully Integrates 59 Receives Order 59 Appears Safe 59 Patent Infringement Litigation 59 Updates Guidance 59 Launches Redesigned 59 Goes Paperless 59 Moves Closer 59 Joins Effort 59 Step Toward 59 Announce Signing 59 Simplifies 59 Has Been Released 59 Aethlon Medical Releases 59 Settle Differences 59 Taro Receives 59 Announce Partnership 59 Announces Formation 59 Eases 59 Be Addressed 59 Announce Merger Agreement 59 Opposes Proposed 59 Ramping Up 59 Extinguishes 59 Finalizes Contract 59 More Than Doubled 59 Antitrust Regulators 59 Voices Concern 59 Report Cites 59 Enters Into Collaboration 59 Emphasizes Importance 59 Negotiations Continue 59 ANADIGICS Announces 59 Obtains Exclusive 59 Experts Advise 59 Strengthens Presence 59 Smooth Transition 59 Issues Shareholder 59 Offers Enhanced 59 Rolls Out 59 Judge Tosses Out 59 Delays Decision 59 Settle Dispute 59 Transmits 59 Lawsuit Dismissed 59 Has Decided 59 Probe Finds 59 Must Carry 59 Unveils Breakthrough 59 Upgrade Path 59 Acquire Controlling Stake 59 Receives Recognition 59 Penetrates 59 Rethinks 59 Monetizes 59 Wide Ranging 59 Procures 59 Vigorously Defend 59 Achieves Prestigious 59 Nears Decision 59 Not Disclosed 59 Exceeds Expectations 59 Antitrust Litig 59 Announces Reseller Agreement 59 Subsidiary Wins 59 Lawsuit Seeks 59 Introduces Expanded 59 Receives Highest Rating 59 Maximize Shareholder Value 59 Finds Fault 59 Tightens Rules 59 Deadline Looming 59 Sees Positive 59 Completes Expansion 59 Newly Launched 59 Merge Healthcare Announces 59 Resolves Litigation 59 Decision Delayed 59 Announces Effectiveness 59 Eligibility Requirements 59 Delayed Indefinitely 59 Unveils Enhanced 59 Sends Warning 59 Legal Dispute 59 Bolsters 59 Can Proceed 59 Unveils Innovative 59 Provides Updates 59 Announce Shareholder Approval 59 Files Shelf Registration Statement 59 Celebrates Successful 59 Announces Discontinuation 59 Revitalizes 59 Under Scrutiny 59 Study Examines 59 Panel Approves 59 Hosts Webinar 59 Launches Groundbreaking 59 Report Criticizes 59 Confirmatory Phase 59 Becomes Official 59 Lawsuit Filed Over 59 Reaffirms Support 59 Relaunches Website 59 Launches Probe Into 59 Accomplishes 59 Feds Propose 59 Compiles 59 Report Suggests 59 Receives Highest 59 Terminates Agreement 59 Regulators Approve 59 Panel Debates 59 Report Identifies 59 Delist From 59 Announce Receipt 59 Being Readied 59 FDA Okays 59 Extend Deadline 59 Improves Survival 59 Signs Definitive Agreement 59 Terminate Merger Agreement 59 Dual Listing 59 Anticipates 59 Lawsuit Filed 59 Has Emerged 59 Immunomedics Announces 59 Holds Talks 59 Makes Debut 59 Draws Attention 59 Poses Risk 59 Q2 Loss Narrows 59 Creates Confusion 59 Recieves 59 Court Upholds 59 Q2 Loss Widens 59 Warning Labels 59 Testifies Before 59 Have Violated 59 Loosens 59 Improves Outcomes 59 Finalized 59 Unveils Powerful 59 Brings Unprecedented 59 Deadline Passes 59 Q4 Loss Widens 59 Readied 59 Executes Agreement 59 Successfully Deploys 59 Cuts Costs 59 Retains Leading 59 Awarded Contracts 59 Announces Restatement 59 Announces Affiliation 59 Rat Poison Found 59 Raises Concerns 59 Jointly Developed 59 RoHS Compliant 59 Hits Roadblock 59 Settles Patent Dispute 59 Help Improve 59 Successful Completion 59 Ruling Delayed 59 Completes Installation 59 Holds Hearings 59 Submits Final 59 Receives Conditional 59 Clinical Trial Evaluating 59 Adopts Revised 59 Appeals Court Upholds 59 Announces Additions 59 Settles Patent 59 Trademark Dispute 59 Goes Offline 59 Achieves Record Sales 59 Announces Resumption 59 Opens Probe Into 59 Announces Proposed 59 Sends Letter 59 #CFR# 59 Announces Upcoming 59 Announce Licensing 59 Subsidiary Enters Into 59 Undercuts 59 Gets Boost 59 Could Backfire 59 Finalize Joint Venture 59 Furthers Commitment 59 Designates 59 Obtains Financing 59 Assess Impact 59 Acquires Controlling Interest 59 Enhances 59 Taglich Brothers Initiates Coverage 59 Dispenses 59 Court Voids 59 Raises Concerns About 59 Enlarges 59 Exec Says 59 Faces Criticism 59 Reduce Risk 59 Patent Infringement Suit 59 Ruled Illegal 59 Q4 Profit Plunges 59 Signs Long Term 59 Defends Itself 59 Proudly Introduces 59 Regain Compliance 59 Eases Rules 59 Successfully Delivers 59 Helps Reduce 59 HITECH HIPAA 59 Lawsuit Involving 59 Slashes Price 59 Shares Plummet 59 Proposes Ban 59 Stands Firm 59 Improve Quality 59 Opts 59 Announces Definitive Agreements 59 Succeeds 59 Lawsuit Filed Against

Back to home page